John W. Hlywak, Jr. (Investors) Jay Higham (Media)
Senior Vice President & CFO President & COO
IntegraMed America, Inc. IntegraMed America, Inc.
(914) 251-4143 (914) 251-4127
email: jhlywak@integramed.com email: jhigham@integramed.com
---------------------- ----------------------
Web Address: http://www.integramed.com
-------------------------
INTEGRAMED INCLUDED IN NEW NASDAQ HEALTH CARE INDEX
Purchase, NY, August 3, 2005 -- IntegraMed America, Inc. (Nasdaq: INMD) today
announced that it has been selected for inclusion in the new NASDAQ Health Care
Index.
On July 27, 2005, the NASDAQ Strategy Index Group announced the new NASDAQ
Health Care Index and named IntegraMed America as a founding member of the
Index. The NASDAQ Health Care Index is a market value weighted index that
contains NASDAQ-listed companies classified, according to the FTSE Global
Classification System, as "Health", "Pharmaceutical", or "Biotechnology". These
classifications include health maintenance organizations, hospital management
and long-tern care, medical equipment and supplies, other health care,
biotechnology and pharmaceutical companies.
The NASDAQ Health Care Index is now a part of the broad selection of world-class
indexes such as the NASDAQ-100 Index and the NASDAQ Biotechnology Index.
"We are pleased to be included in the new NASDAQ Health Care Index as it
provides market participants new opportunities to own shares of IntegraMed
through an additional investment vehicle", commented Gerardo Canet, Chairman and
Chief Executive Officer of IntegraMed America, Inc.
About IntegraMed America, Inc.
IntegraMed, based in Purchase, NY offers products and services to patients,
providers and payers focused on the $2 billion fertility industry. IntegraMed
provides business services to a national network of fertility centers;
distributes pharmaceutical products and treatment financing programs directly to
consumers; and operates http://www.integramed.com, a leading fertility portal.
Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed America are forward-looking statements that may
involve a number of risks and uncertainties. Actual results may differ
materially from the statements made as a result of various factors, including,
but not limited to, the risks associated with the Company's ability to finance
future growth; the loss of significant business service contract(s);
profitability at Reproductive Science Centers serviced by IntegraMed America;
changes in insurance coverage, government laws and regulations regarding health
care or managed care contracting; and other risks, including those identified in
the Company's most recent Form 10-K and in other documents filed by the Company
with the U.S. Securities and Exchange Commission. All information in this press
release is as of August 3, 2005 and IntegraMed undertakes no duty to update this
information.
# # # #